Drug Approval | December 25, 2023
Eugia's East Windsor facility gets 10 observations from USFDA
The plant is yet to start commercial operations
The plant is yet to start commercial operations
The transfer of the distribution rights will strengthen Sandoz's immunology and biosimilar portfolio
The commissioning of the facility represents the culmination of a £45m investment to address rapidly growing demand for ADC manufacturing, supported by a £2.4m Scottish Enterprise grant
The bioprocess business will continue to pioneer contributions to safety and productivity in the manufacture of biotherapeutics
Studies have demonstrated that ZYIL1 is highly potent and can suppress inflammation caused by NLRP3 inflammasome activation
Biocon Biologics is one among the three pharmaceutical companies from India to be featured on this year's list
Dr. Reddy's has been awarded 'Gold Medal' status by EcoVadis
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
This acquisition marks Max Healthcare's entry into Lucknow
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Subscribe To Our Newsletter & Stay Updated
